leukemia

Galecto buys leukemia drug, drops bone cancer asset in pivot

A year after the failure of a fibrosis drug sent Galecto on a search for salvation, the biotech has decided to go all-in on oncology and liver disease

James Waldron Oct 7, 2024 10:07am

Graphic of a drop of blood made up of small data points and nodes

Kura's leukemia drug works best when tacked onto existing combo

Jan 30, 2024 11:15am

FDA lets Curis resume enrollment for phase 1/2 leukemia study

Aug 31, 2022 7:50am

FDA lifts clinical hold on Curis' phase 1/2 lymphoma trial

Aug 18, 2022 11:23am

Acadia culls painkiller rival to Vertex and cancer drug

Aug 9, 2022 10:21am

layoffs job cuts fired exit restructuring layoff reduction

X4 joins handful of biotechs sending staff out the door

Jul 21, 2022 10:55am